The Ohio State University Wexner Medical Center

Health Technology

BroadcastMed | January 25, 2024

BroadcastMed, the leading healthcare information marketplace that provides trusted clinical content, powerful engagement, and industry insights to healthcare professionals (HCPs), medical institutions and manufacturers, service providers, and pharmaceutical companies, is thrilled to announce the evolution of its Vision portfolio. PentaVision, powered by BroadcastMed, released a new digital platform designed to elevate the user experience for healthcare and optical professionals. Driven by ...

Managed Healthcare Executive | January 20, 2020

Innovaccer, Inc., a leading healthcare technology company, released its first-ever in-house survey report describing the revolutionary two-fold strategy for healthcare organizations to succeed in the changing landscape of value-based care in the U.S., according to a news release. The Science of Value-Based Care: An Industry View, positions healthcare stakeholders in the current scenario of value-based care. It maps the route from the immediate challenges faced by healthcare organizations to the ...

Healthcare Analytics

Definitive Healthcare | November 02, 2020

Definitive Healthcare, the main supplier of information, knowledge, and investigation on the healthcare market, today reported its procurement of Monocl, the pre-prominent membership based supplier of clinical and logical master information and experiences. With this securing, Definitive Healthcare widens its help of clients inside its quickly developing life sciences section with basic information resources and examina...

Health Technology

Antengene Corporation Limited | September 19, 2022

Antengene Corporation Limited a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematology and oncology, announced that ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. This ODD will help Antenge...